Around 25,000 people die in the European Union each year from infections resistant to antibiotics. Third-generation cephalosporins are often useless against common bacteria like Escherichia coli, and fluoroquinolones are no longer the treatment of choice for gonorrhoea because resistance has become widespread. Here, you can find news stories and articles about the issue.
Pharmacy-driven allergy assessments can provide cost savings for patients with a reported penicillin allergy, a study presented at the American Society of Health System Pharmacists’ 54th Midyear Clinical Meeting has shown.
More than half of acute trusts in England failed to reduce their antibiotic use between 2017/2018 and 2018/2019, according to figures analysed by The Pharmaceutical Journal.
Patients in England contracted 165 antibiotic resistant infections per day in 2018, a Public Health England report has estimated.
Little progress made to develop incentives for new antibiotics, vaccines and diagnostics, AMR review concludes
Little progress has been made to transform research or develop incentives for new antibiotics, vaccines and diagnostics, a review of progress on antimicrobial resistance has concluded.
Despite the rise of resistant infections, national figures show that antibiotic use continues to grow in hospitals. However, some trusts in England are stepping up their stewardship efforts and achieving significant reductions. Here, three trusts share the secrets to their success.
An overview of the 2018 guideline for management of this sexually transmitted infection in men and women.
Rising antimicrobial resistance (AMR) is a recognised threat to global health. There is a perception that poor prescribing practices contribute to the problem, although data confirming this are limited. Reliable data on the quality of antimicrobial prescribing in UK hospitals are not available, with hospital drug-purchasing data most often being used ...
Pharmaceutical companies won’t develop fast, cheap and effective diagnostic tools on their own — incentives are the missing piece to tackling antimicrobial resistance.
Simply reducing the use of antibiotics, while discovering new ones, is not enough to keep resistance at bay — healthcare professionals need to understand bacteria’s evolutionary biology if they are to subvert it.
Given the hot topic of antimicrobial resistance, one could only be shocked at reading New Scientist’s article ‘How antibiotic resistance is driven by pharmaceutical pollution’ (22 May 2019), which details the prolific dumping of antibiotic ...